Dr. Mowrey collaborates on projects in the areas of radiology, psychiatry, neurology, neurosurgery, neuroscience, rheumatology, allergy/Immunology and nephrology, etc. Her statistical methodology interests include analysis of neuroimaging data from all modalities (PET, MRI, fMRI, DTI, EEG, MEG and optical imaging), sparse clustering methods, dimension reduction of high dimensional data, survival and longitudinal data analysis.

1. Mowrey WB, Lipton RB, Katz MJ, Ramratan WS, Loewenstein DA, Zimmerman ME, Buschke H. Memory Binding Test predicts incident dementia: Results from the Einstein Aging Study. Journal of Alzheimer's Disease, 62(1):293-304, 2018.
2. Mowrey WB, Lipton RB, Katz MJ, Ramratan WS, Loewenstein DA, Zimmerman ME, Buschke H. Memory Binding Test predicts incident amnestic mild cognitive impairment. Journal of Alzheimer's Disease, 53(4):1585-95, 2016.
3. Buschke H*, Mowrey WB*, Ramratan WS, Zimmerman ME, Loewenstein DA, Katz MJ, Lipton RB. Memory Binding Test distinguishes amnestic mild cognitive impairment and dementia from cognitively normal elderly. Archives of Clinical Neuropsychology, 32(1):29-39, 2017. * Equal contribution.
4. Galanopoulou AS, Mowrey WB. Not all that glitters is gold: A guide to critical appraisal of animal drug trials in epilepsy. Invited review. Epilepsia Open, 1(3-4):86-101, 2016.
5. Briggs SW, Mowrey W, Hall CB, Galanopoulou AS. CPP-115, a vigabatrin analogue, suppresses spasms in the multiple-hit rat model of infantile spasms. Epilepsia, 55(1):94-102, 2014.
6. Broder A*, Mowrey WB*, Golestaneh L, Putterman C, Costenbader KH, Kim M. Methodological considerations in comparing access to pre-emptive renal transplantation between SLE and other ESRD causes in the USRDS. Seminars in Arthritis and Rheumatism, Accepted, 2018. * Equal contribution.
7. Broder A, Mowrey W, Kim M, Murakhovskaya I, Billett H, Neugarten J, Costenbader KH, Putterman C. Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study. Rheumatology (Oxford, England), 55(5):817-25, 2015.
8. Cohen AD, Mowrey W, Weissfeld LA, Aizenstein HJ, McDade E, Mountz JM, Nebes RD, Saxton JA, Snitz B, Dekosky S, Williamson J, Lopez OL, Price JC, Mathis CA, Klunk WE. Classification of amyloid-positivity in controls: Comparison of visual read and quantitative approaches. NeuroImage, 71:207-215, 2013.